Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-morbidity Factors Part B, Volume 172 in the International Review of Neurobiology series, highlights new advances in the field with this new volume presenting interesting chapters on Spinal cord injury induced exacerbation of Alzheimer's disease pathophysiology in the cord is reduced by topical application of nanowired cerebrolysin and antibodies to tumor necrosis factor alpha, Nanodelivery of histamine H3 receptor inverse agonist BF-2549 with clobenpropit a H3 receptor antagonist and H4 receptor agonist induced neuroprotection in spinal cord injury is potentiated by antioxidant compound H-290/51, and Neuromodulation and quality of life for patient with spasticity after spinal cord injury, and much more.
Other sections cover Efficacy of invasive and non-invasive methods for the treatment of Parkinson ́s disease: nanodelivery and enriched environment, Co-administration of DL-3-n-butylphthalide and neprilysin is neuroprotective in Alzheimer disease associated with brain injury, Nicotine Neurotoxicity Exacerbation following Engineered Ag and Cu (50-60 nm) nanoparticles intoxication. Neuroprotection with nanowired delivery of antioxidant compound H-290/51 together with serotonin 5-HT3 receptor antagonist ondansetron, and more.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Series Page - p. iii 5. Copyright - p. iv 6. Contributors - p. iv 7. Preface - p. xvii 8. Acknowledgements - p. xxiii 9. Section 1 Spinal cord Injury - p. 2 10. Chapter One: Spinal cord injury induced exacerbation of Alzheimer's disease like pathophysiology is reduced by topical application of nanowired cerebrolysin with monoclonal antibodies to amyloid beta peptide, p-tau and tumor necrosis factor alpha - p. 3 11. Chapter Two: Nanodelivery of histamine H3 receptor inverse agonist BF-2649 with H3 receptor antagonist and H4 receptor agonist clobenpropit induced neuroprotection is potentiated by antioxidant compound H-290/51 in spinal cord injury - p. 39 12. Chapter Three: Neuromodulation and quality of life for patient with spasticity after spinal cord injury - p. 80 13. Section 2 Neurodegenerative disease - p. 102 14. Chapter Four: Efficacy of invasive and non-invasive methods for the treatment of Parkinson’s disease: Nanodelivery and enriched environment - p. 104 15. Chapter Five: Co-administration of DL-3-n-butylphthalide and neprilysin is neuroprotective in Alzheimer disease associated with mild traumatic brain injury - p. 147 16. Section 3 Drugs of abuse and neurotoxicity - p. 188 17. Chapter Six: Nicotine neurotoxicity exacerbation following engineered Ag and Cu (50–60 nm) nanoparticles intoxication. Neuroprotection with nanowired delivery of antioxidant compound H-290/51 together with serotonin 5-HT3 receptor antagonist ondansetron - p. 191 18. Section 4 Clinical neurology and oncology - p. 236 19. Chapter Seven: Technology of genomic balancing of chromatin of autologous hematopoietic stem cells for gene therapy of fatal immune-mediated diseases of civilization, extended life expectancy and sudden human death prevention - p. 239 20. Chapter Eight: An overview of Twist1 in glioma progression and recurrence - p. 286 21. Chapter Nine: A review of traditional Chinese medicine Curcumae Rhizoma for treatment of glioma - p. 304 22. Chapter Ten: Case report of epileptic seizure during awake craniotomy of functional area glioma and literature study - p. 321
Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-morbidity Factors Part B, Volume 172 in the International Review of Neurobiology series, highlights new advances in the field with this new volume presenting interesting chapters on Spinal cord injury induced exacerbation of Alzheimer's disease pathophysiology in the cord is reduced by topical application of nanowired cerebrolysin and antibodies to tumor necrosis factor alpha, Nanodelivery of histamine H3 receptor inverse agonist BF-2549 with clobenpropit a H3 receptor antagonist and H4 receptor agonist induced neuroprotection in spinal cord injury is potentiated by antioxidant compound H-290/51, and Neuromodulation and quality of life for patient with spasticity after spinal cord injury, and much more.
Other sections cover Efficacy of invasive and non-invasive methods for the treatment of Parkinson ́s disease: nanodelivery and enriched environment, Co-administration of DL-3-n-butylphthalide and neprilysin is neuroprotective in Alzheimer disease associated with brain injury, Nicotine Neurotoxicity Exacerbation following Engineered Ag and Cu (50-60 nm) nanoparticles intoxication. Neuroprotection with nanowired delivery of antioxidant compound H-290/51 together with serotonin 5-HT3 receptor antagonist ondansetron, and more.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Series Page - p. iii 5. Copyright - p. iv 6. Contributors - p. iv 7. Preface - p. xvii 8. Acknowledgements - p. xxiii 9. Section 1 Spinal cord Injury - p. 2 10. Chapter One: Spinal cord injury induced exacerbation of Alzheimer's disease like pathophysiology is reduced by topical application of nanowired cerebrolysin with monoclonal antibodies to amyloid beta peptide, p-tau and tumor necrosis factor alpha - p. 3 11. Chapter Two: Nanodelivery of histamine H3 receptor inverse agonist BF-2649 with H3 receptor antagonist and H4 receptor agonist clobenpropit induced neuroprotection is potentiated by antioxidant compound H-290/51 in spinal cord injury - p. 39 12. Chapter Three: Neuromodulation and quality of life for patient with spasticity after spinal cord injury - p. 80 13. Section 2 Neurodegenerative disease - p. 102 14. Chapter Four: Efficacy of invasive and non-invasive methods for the treatment of Parkinson’s disease: Nanodelivery and enriched environment - p. 104 15. Chapter Five: Co-administration of DL-3-n-butylphthalide and neprilysin is neuroprotective in Alzheimer disease associated with mild traumatic brain injury - p. 147 16. Section 3 Drugs of abuse and neurotoxicity - p. 188 17. Chapter Six: Nicotine neurotoxicity exacerbation following engineered Ag and Cu (50–60 nm) nanoparticles intoxication. Neuroprotection with nanowired delivery of antioxidant compound H-290/51 together with serotonin 5-HT3 receptor antagonist ondansetron - p. 191 18. Section 4 Clinical neurology and oncology - p. 236 19. Chapter Seven: Technology of genomic balancing of chromatin of autologous hematopoietic stem cells for gene therapy of fatal immune-mediated diseases of civilization, extended life expectancy and sudden human death prevention - p. 239 20. Chapter Eight: An overview of Twist1 in glioma progression and recurrence - p. 286 21. Chapter Nine: A review of traditional Chinese medicine Curcumae Rhizoma for treatment of glioma - p. 304 22. Chapter Ten: Case report of epileptic seizure during awake craniotomy of functional area glioma and literature study - p. 321
